The Management
Board of Directors
As Geistlich Pharma has always proven, its business is long-term. The five-member Board of Directors of Geistlich Pharma AG is responsible for the strategic orientation of the company with its three business units. Its members are:
- Dr. Andreas Geistlich, President of the Board of Directors
- Jakob Hirzel, Vice-President
- Dr. Martin Geistlich, Member of the Board
- Prof. Dr. Simon P. Hoerstrup, Member of the Board
- Paul Note (CEO Geistlich Pharma AG), Member of the Board and Delegate
Paul Note, Prof. Dr. Simon P. Hoerstrup, Dr. Andreas Geistlich, Dr. Martin Geistlich, Jakob Hirzel (left to right).
The Executive Committee is responsible for the operational management, strategy and organisation of Geistlich Pharma AG and for the implementation of the strategic business plans approved by the Board of Directors for the company and its three business units. Its members are:
- Paul Note, Chief Executive Officer (CEO)
- Dr. Ralf P. Halbach, (Designated CEO)
- Dr. Matthias Dunkel, Chief Operating Officer (COO)
- Juerg Roth, Chief Financial Officer (CFO)
- Dr. Mark Spilker, Chief Scientific Officer (CSO)
- Dr. Terance Hart, Director Research
- Rolf Jeger, Director Governance, Risk & Compliance (GRC)
Rolf Jeger, Juerg Roth, Paul Note, Dr. Ralf P. Halbach, Dr. Matthias Dunkel, Dr. Mark Spilker, Dr. Terance Hart (left to right).
